Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
F1000Research
|
January 13, 2015
Collecting rare diseases
Sean Ekins
F1000Research
|
March 24, 2015
FDA approved drugs as potential Ebola treatments
Sean Ekins, Megan Coffee
F1000Research
|
August 1, 2015
Finding small molecules for the 'next Ebola'
Sean Ekins, Christopher Southan, Megan Coffee
F1000Research
|
February 26, 2015
Small molecules with antiviral activity against the Ebola virus
Nadia Litterman, Christopher Lipinski, Sean Ekins
F1000Research
|
September 21, 2017
The new alchemy: Online networking, data sharing and research activity distribution tools for scientists
Antony J Williams, Lou Peck, Sean Ekins
F1000Research
|
February 10, 2015
A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus
Sean Ekins, Joel S Freundlich, Megan Coffee
F1000Research
|
July 18, 2014
Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal Neuropathy
Lori Sames, Allison Moore, Renee Arnold, et al.
F1000Research
|
February 17, 2015
Collaboration for rare disease drug discovery research
Nadia K Litterman, Michele Rhee, David C Swinney, et al.
F1000Research
|
August 8, 2017
Machine learning models identify molecules active against the Ebola virus <i>in vitro</i>
Sean Ekins, Joel S Freundlich, Alex M Clark, et al.
F1000Research
|
October 21, 2016
Illustrating and homology modeling the proteins of the Zika virus
Sean Ekins, John Liebler, Bruno J Neves, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
F1000Research
|
January 13, 2015
Collecting rare diseases
Sean Ekins
F1000Research
|
March 24, 2015
FDA approved drugs as potential Ebola treatments
Sean Ekins, Megan Coffee
F1000Research
|
August 1, 2015
Finding small molecules for the 'next Ebola'
Sean Ekins, Christopher Southan, Megan Coffee
F1000Research
|
February 26, 2015
Small molecules with antiviral activity against the Ebola virus
Nadia Litterman, Christopher Lipinski, Sean Ekins
F1000Research
|
September 21, 2017
The new alchemy: Online networking, data sharing and research activity distribution tools for scientists
Antony J Williams, Lou Peck, Sean Ekins
F1000Research
|
February 10, 2015
A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus
Sean Ekins, Joel S Freundlich, Megan Coffee
F1000Research
|
July 18, 2014
Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal Neuropathy
Lori Sames, Allison Moore, Renee Arnold, et al.
F1000Research
|
February 17, 2015
Collaboration for rare disease drug discovery research
Nadia K Litterman, Michele Rhee, David C Swinney, et al.
F1000Research
|
August 8, 2017
Machine learning models identify molecules active against the Ebola virus <i>in vitro</i>
Sean Ekins, Joel S Freundlich, Alex M Clark, et al.
F1000Research
|
October 21, 2016
Illustrating and homology modeling the proteins of the Zika virus
Sean Ekins, John Liebler, Bruno J Neves, et al.
Page
of 2